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SUMMARY
Polyubiquitination of proliferating cell nuclear antigen (PCNA) regulates the error-free template-
switching mechanism for the bypass of DNA lesions during DNA replication. PCNA polyubiquitination
is critical for the maintenance of genomic integrity; however, the underlying mechanism is poorly un-
derstood. Here, we demonstrate that tonicity-responsive enhancer-binding protein (TonEBP) regu-
lates PCNA polyubiquitination in response to DNA damage. TonEBP was recruited to DNA damage
sites with bulky adducts and sequentially recruited E3 ubiquitin ligase SHPRH, followed by deubiqui-
tinase USP1, to DNA damage sites, in correlation with the dynamics of PCNA polyubiquitination. Simi-
larly, TonEBP was found to be required for replication fork protection in response to DNA damage.
The Rel-homology domain of TonEBP, which encircles DNA, was essential for the interaction with
SHPRH and USP1, PCNA polyubiquitination, and cell survival after DNA damage. The present findings
suggest that TonEBP is an upstream regulator of PCNA polyubiquitination and of the DNA damage
bypass pathway.
INTRODUCTION
DNA damage, such as bulky adducts, causes DNA polymerase stalling. DNA damage tolerance mecha-
nisms allow for a bypass of DNA lesions to suppress the collapse of the DNA replication fork (Berti and Vin-
digni, 2016). Two DNA damage tolerance mechanisms have been identified: translesion synthesis and tem-
plate switching. In translesion synthesis, error-prone translesion DNA polymerases replace replicative DNA
polymerases in response to proliferating cell nuclear antigen (PCNA) monoubiquitination at the expense of
the increased mutation rate (Berti and Vindigni, 2016; Kannouche and Lehmann, 2004). Template switching
is initiated by polyubiquitination of PCNA and is an error-free pathway of DNA lesion bypass mediated by
an uncharacterized mechanism.
PCNA polyubiquitination in mammals is catalyzed by ubiquitin E3 ligases SHPRH and HLTF (Motegi et al.,
2006, 2008; Unk et al., 2006, 2008), whereas PCNA deubiquitination is catalyzed by USP1 (Huang et al.,
2006). There are two potential models explaining the role of PCNA polyubiquitination in the DNA dam-
age bypass. In one model, PCNA polyubiquitination facilitates filling of postreplicative single-stranded
DNA (ssDNA) gaps via template switching and recombinational mechanisms involving sister chromatid
junctions (Berti and Vindigni, 2016; Giannattasio et al., 2014). An alternative model of error-free bypass
and template switching entails remodeling of the replication fork in a four-way junction, a process known
as replication fork reversal, to enable template switching to occur directly in the elongating fork (Higgins
et al., 1976).
SHPRH is a mammalian homolog of S. cerevisiae Rad5. SHPRH polyubiquitinates PCNA to promote DNA
lesion bypass via an unknown recombination-dependent pathway (Motegi et al., 2006; Unk et al., 2006).
These functions of SHPRH are mediated by interactions with PCNA, RAD18, and UBC13. USP1 regulates
several important steps in DNA damage response, mainly in the Fanconi anemia (FA) pathway and in
the process of translesion synthesis (Huang et al., 2006; Nijman et al., 2005). FA is a genomic instability dis-
order caused by mutations in genes regulating the replication-dependent removal of interstrand DNA
cross-links (D’Andrea andGrompe, 2003; Kais et al., 2016). Recent evidence suggests that USP1 contributes
to the regulation of differentiation in specific cellular contexts. USP1 is activated by forming a heterodi-
meric complex with its cofactor USP1-associated factor 1 (UAF1) (Cohn et al., 2009).
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Tonicity-responsive enhancer-binding protein (TonEBP), also known as nuclear factor of activated T cells 5
(NFAT5), belongs to the Rel family of DNA-binding transcription factors, which includes nuclear factor
(NF)-kB and NFAT (Miyakawa et al., 1999). TonEBP is involved in a variety of processes including transcrip-
tional regulation and transcriptional stimulation through sequence-specific DNA binding (Miyakawa et al.,
1999) and acts as a transcriptional cofactor of NF-kB (Lee et al., 2016a) and a transcriptional suppressor of
genes PPARg and IL-10 (Choi et al., 2016; Lee et al., 2015). TonEBP upregulation is crucial in inflammatory
diseases, including rheumatoid arthritis (Yoon et al., 2011), atherosclerosis (Halterman et al., 2012), and dia-
betic nephropathy (Choi et al., 2018). TonEBP upregulation promotes hepatocellular carcinogenesis (Lee
et al., 2019). According to our present data, the function of TonEBP in DNA damage response is unrelated
to the regulation of transcription.
Protein interactome studies help to identify new functions of proteins of interest (Feng et al., 2016; Gingras
et al., 2007; Lee et al., 2016b; Scott et al., 2017). TonEBP is similar to PCNA in terms of the mechanism of
DNA encirclement. Because PCNA is an important factor in DNA metabolism, proteomic analysis was per-
formed here to determine whether TonEBP is also involved in DNA metabolism. In these experiments, we
identified interactions of TonEBP with SHPRH and USP1.
In the present study, we showed that TonEBP functions as an early sensor of the DNA damage response.
TonEBP was found to be recruited to DNA damage sites with bulky adducts and to regulate PCNA poly-
ubiquitination through sequential interactions with SHPRH and USP1. Accordingly, TonEBP suppressed
cell death caused by mutagenesis in response to DNA damage.
RESULTS
TonEBP Is Recruited to DNA Damage Sites and Interacts with Proteins Involved in PCNA
Polyubiquitination
TonEBP binds to its cognate DNA sequence using the Rel-homology domain (RHD) similar to the RHD of
transcription factors NFAT and NF-kB. The RHD of TonEBP forms a homodimer that completely encircles
DNA, thereby creating a protein ring (Figure 1A) (Stroud et al., 2002). Because the inner diameter of the
protein ring is larger than the outer diameter of DNA, the DNA surface is not in full contact with the protein
in the circle. These unusual features of the TonEBP RHD point to a possible function of TonEBP in DNA sur-
veillance. To test this possibility, the subcellular localization of TonEBP was monitored after treatment with
a DNA-damaging agent. Exposure to the alkylating agent methyl methanesulfonate (MMS) for 30 min re-
sulted in the localization of TonEBP at the sites of DNA damage and the formation of damage-induced foci
(Figure 1B), suggesting that TonEBP helps to detect DNA damage. TonEBP foci formation was induced
only by MMS, and not by UV light, HU (hydroxyurea), or mitomycin C (Figure S1A).
To identify the DNA repair pathway involving TonEBP, TonEBP-interacting proteins were found by
screening via tandem affinity purification. We identified 465 proteins that interacted with the N terminus
of TonEBP (Yc1), which encompasses the entire RHD, including known DNA repair proteins SHPRH (ubiq-
uitin E3 ligase) and USP1 (deubiquitinase) (Figure 1C and Table S1). SHPRH (Motegi et al., 2006; Unk et al.,
2006) and USP1 (Huang et al., 2006) regulate PCNA ubiquitination in response to DNAdamage during DNA
replication in the template-switching pathway.
TonEBP Interacts with SHPRH and USP1 via Its RHD
To confirm the interaction between TonEBP and SHPRH or USP1, endogenous TonEBP and SHPRH were
coimmunoprecipitated (Figure 1D). Immunoprecipitation (IP) with an anti-TonEBP or anti-SHPRH antibody
coprecipitated SHPRH or TonEBP, respectively. This interaction was confirmed using ectopically expressed
TonEBP and SHPRH (Figure S1B). The interactions of USP1 and UAF1, an essential cofactor of USP1, with
TonEBP were confirmed by coimmpunoprecipitation (coIP) (Figures 1E, S1C, and S1E). Despite the oppo-
site effects of SHPRH and USP1 on PCNA ubiquitination, they interacted with each other (Figure S1D). To
rule out an indirect interaction between TonEBP and SHPRH or USP1 through DNA, whole-cell extracts
were preincubated with ethidium bromide (EtBr, which intercalates DNA) or benzonase, which degrades
DNA before coIP. Preincubation with EtBr or benzonase did not affect the interaction between TonEBP
and SHPRH or USP1 (Figures 1F and S1F). Collectively, these results indicated that TonEBP interacts
with ubiquitin E3 ligase SHPRH and deubiquitinating enzyme complex USP1–UAF1, suggesting that
TonEBP participates in PCNA polyubiquitination.
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To determine the domains involved in the interaction between TonEBP and SHPRH, serial deletionmutants
of proteins TonEBP and SHPRH (Figures 2A and 2B) were generated and their interactions were examined.
CoIP with the serial deletion mutants of TonEBP revealed that the RHD of TonEBP was required for the
interaction with SHPRH, whereas the C-terminal portion of RHD named IPT was dispensable (Figure 2C).
Figure 1. TonEBP Forms Foci in Response to DNA Damage and Interacts with SHPRH and USP1
(A) Crystal structure of a homodimer of the Rel-homology domain (RHD) of TonEBP. The DNA-binding pocket is shown in
the center (PDB: 1IMH).
(B) HeLa cells treated with methyl methanesulfonate (MMS, 0.01%) for 30 min were fixed and immunostained for TonEBP.
Top: Representative image of a nucleus in each condition. Bottom: The percentage of cells with TonEBP foci (out of
150 nuclei) expressed as the mean G SD, n = 3; **p < 0.01. Scale bar, 2 mm.
(C) The TonEBP interactome of the PCNA ubiquitination pathway including SHPRH and USP1 (according to String v.9.1).
(D and E) HEK293 cell lysates were immunoprecipitated (IP) with the indicated antibodies. Cells treated with normal serum
(Serum) served as the negative control. An anti-TonEBP antibody (TonEBP) (top) and anti-SHPRH (SHPRH) antibody
(middle) were used for IP (D). An anti-TonEBP antibody (top) and anti-USP1 antibody (USP1) (middle) were used for IP (E).
Precipitated proteins were detected with the indicated antibodies.
(F) HEK293 cells were transfected with plasmids expressing proteins FLAG-TonEBP, Myc-SHPRH, and HA-USP1. Cell
lysates were immunoprecipitated with an anti-FLAG antibody. Precipitated proteins were detected with the indicated
antibodies. EtBr (at 0.1 mg/mL) was added during the IP reaction to eliminate indirect interactions through DNA.
iScience 19, 177–190, September 27, 2019 179
Figure 2. The RHD of TonEBP Is Required for the Interaction with SHPRH and USP1
(A) A schematic of the domain structures of full-length (FL) human TonEBP and the serial deletion constructs Yc1, Yc1
DIPT, and Yc1 DRHD.
(B) A schematic of the domain structures of FL human SHPRH and the serial deletion constructs SHPRH RINGm and
SHPRH SNF2-N2m.
(C) HEK293 cells were transfected with plasmids expressing Myc-tagged SHPRH together with FLAG-tagged Yc1, Yc1
DIPT, or Yc1 DRHD. Proteins immunoprecipitated with an anti-Myc antibody were detected with the anti-FLAG antibody.
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The interaction of TonEBP with USP1 required the entire RHD including IPT (Figure 2D), suggesting that
SHPRH and USP1 interact with TonEBP through different sections of the RHD. The SNF2-N2 domain of
SHPRH was required for the interaction with TonEBP (Figure 2E). These data indicated that TonEBP inter-
acts with SHPRH and USP1 through distinct sections of the RHD. It is possible that the Yc1 fragment of
TonEBP dimerizes with endogenous full-length TonEBP. To rule out this possibility, we depleted TonEBP
expression before interaction analysis. TonEBP depletion did not affect the interaction among Yc1, SHPRH,
and USP1 (Figures S2A and S2B).
TonEBP Regulates MMS-Induced PCNA Polyubiquitination through Recruitment of SHPRH
and USP1 to DNA Damage Sites via Dynamic Interactions
SHPRH ubiquitinates PCNA, whereas USP1 deubiquitinates PCNA, for the template-switching DNA dam-
age bypass pathway (Figures S3A and S3B) (Motegi et al., 2008; Vujanovic et al., 2017). We hypothesized
that TonEBP regulates PCNA ubiquitination in response to DNA damage by interacting with SHPRH and
USP1. To test this hypothesis, the effect of a TonEBP knockdown on MMS-induced PCNA poly-
ubiquitination was assessed. PCNA polyubiquitination was increased by the TonEBP knockdown (Figures
3A and 3B). Nonetheless, the TonEBP knockdown reduced PCNA polyubiquitination in response to MMS
treatment (Figure 3A). When we monitored PCNA polyubiquitination after removing MMS, PCNA poly-
ubiquitination decreased in a time-dependent manner in the TonEBP knockdown group (Figure 3B),
thereby explaining the attenuation of MMS-induced PCNA polyubiquitination in the TonEBP knockdown
group compared with scrambled control groups as shown in Figure 3A. On the basis of these observations,
we hypothesized that TonEBP recruits SHPRH and USP1 to damaged DNA in a dose-dependent manner.
To test this hypothesis, TonEBP was expressed to various degrees, and PCNA polyubiquitination wasmoni-
tored. At low TonEBP expression after transfection of 0.2 mg of the expression plasmid, PCNA poly-
ubiquitination was induced. In contrast, transfection of 1 mg of the TonEBP expression plasmid reduced
PCNA polyubiquitination (Figure 3C). SHPRH or USP1 depletion at low or high TonEBP expression, respec-
tively, abrogated the changes of PCNA polyubiquitination by TonEBP (Figures S4A and S4B). SHPRH or
USP1 were found to cause the changes in PCNA polyubiquitination at low or high TonEBP expression,
respectively. To rule out the possibility that changes of PCNA polyubiquitination by TonEBP expression
are due to the changes of SHPRH or USP1 expression by the TonEBP knockdown, we measured the expres-
sion of SHPRH and USP1 upon TonEBP knockdown. This knockdown did not affect the levels of SHPRH and
USP1 either in the no-damage or in the MMS treatment group (Figures S5A and S5B). We additionally
checked TonEBP function in UV light-induced PCNA polyubiquitination. Although PCNA poly-
ubiquitination was mildly induced by UV light, TonEBP knockdown reduced UV light-induced PCNA poly-
ubiquitination (Figure S6A). HLTF, an E3 ubiquitin ligase involved in UV light-induced PCNA ubiquitination
(Motegi et al., 2008), interacted with TonEBP (Figure S6B). Given that SHPRH and HLTF interact with each
other (Lin et al., 2011), we tested whether the interaction between TonEBP and HLTF is mediated by
SHPRH. SHPRH knockdown reduced the interaction between TonEBP and HLTF (Figure S6C), suggesting
that UV-induced PCNA polyubiquitination is regulated by TonEBP-SHPRH-HLTF interaction.
The regulation of PCNA polyubiquitination by TonEBP could be mediated by the activation of SHPRH or
suppression of USP1 because TonEBP interacts with SHPRH and USP1 (Figures 1D and 1E). High ectopic
expression of TonEBP suppressed PCNA ubiquitination in response to MMS treatment (Figure 3C). Both
TonEBP knockdown and TonEBP overexpression decreased PCNA polyubiquitination, suggesting that
TonEBP modulates PCNA ubiquitination by recruiting SHPRH or USP1 to DNA damage sites. To test
this hypothesis, we investigated the temporal interactions of TonEBP with SHPRH and USP1 after DNA
damage. Coexpression of TonEBP, SHPRH, and USP1 resulted in the reciprocal coIP of USP1 or SHPRH
(Figure S7), suggesting that the three proteins form a complex. Nevertheless, assessment of the temporal
pattern of these interactions in response to MMS treatment and in comparison with the timeline of PCNA
ubiquitination showed an increased interaction between TonEBP and SHPRH at 1 h after MMS treatment,
concomitantly with a decreased interaction between TonEBP and USP1 (Figure 3D). The interaction
Figure 2. Continued
(D) HEK293 cells were transfected with a plasmid expressing HA-USP1 together with a plasmid expressing FLAG-tagged
Yc1, Yc1 DIPT, or Yc1 DRHD. Proteins immunoprecipitated with an anti-hemagglutinin (HA) antibody were detected with
the anti-FLAG antibody.
(E) HEK293 cells were transfected with a plasmid expressing FLAG-Yc1 together with a plasmid expressingMyc-tagged FL
SHPRH, RINGm SHPRH, or SNF2-N2m SHPRH. Proteins immunoprecipitated with the anti-FLAG antibody were detected
with the anti-Myc antibody.
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Figure 3. Dynamic Interactions between TonEBP and SHPRH or USP1 on DNA Damage Sites Regulate PCNA Polyubiquitination
(A) HEK293 cells transfected with control (scrambled) siRNA (S) or TonEBP-targeting siRNA (T) were treated with 0.01% (v/v) MMS for 1 h as indicated. PCNA
bound to chromatin was immunoprecipitated and detected with an anti-PCNA antibody (top) after removal of MMS in 4 h. PCNA-(Ub)n indicates
polyubiquitinated PCNA. Cell lysates were also immunoblotted (bottom).
(B) HEK293 cells transfected with TonEBP-targeting siRNA (T) were treated with 0.01% (v/v) MMS for 1 h. PCNA bound to chromatin was immunoprecipitated
and detected with an anti-PCNA antibody after removal of MMS according to the indicated timeline.
(C) HEK293 cells transfected with TonEBP-targeting siRNA (T) and with plasmids expressing TonEBP at various doses (as indicated) were treated with 0.01%
(v/v) MMS for 1 h. PCNA bound to chromatin was immunoprecipitated and detected with the anti-PCNA antibody.
(D) HEK293 cells transfected with plasmids expressing hemagglutinin (HA)-TonEBP, FLAG-USP1, and Myc-SHPRH were treated with 0.01% (v/v) MMS for 1 h.
Cells without MMS treatment served as the negative control (). Cells treated with MMS were washed with a fresh medium and incubated for 1–4 h as
indicated. Cell lysates from each time point were immunoprecipitated with the anti-HA antibody, and the indicated proteins were detected with each
antibody. Chromatin-bound fractions were prepared separately, and PCNA was detected in the same way as in Figure 3A (bottom).
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between TonEBP and SHPRH started to decrease at 2 h after the removal of MMS, whereas the interaction
between TonEBP and USP1 increased at 4 h after the removal of MMS. Consistent with these findings,
PCNA ubiquitination peaked at 1 h and declined after MMS treatment. These results indicated that TonEBP
regulates PCNA polyubiquitination through dynamic temporal interactions with SHPRH and USP1 in
response to MMS treatment.
To independently confirm the role of TonEBP in the recruitment of SHPRH and USP1 to DNA damage sites
through dynamic interaction changes, protein recruitment to defined sites of DNA damage was measured
by chromatin immunoprecipitation (ChIP). Nucleotides 13502–13724 in intron 7 of TP53 contain well-char-
acterized DNA damage sites (Figure S8A) (Jiang and Sancar, 2006). To prove that DNA was damaged in our
DNA-damaging condition, localization of RPA32 and ATR to the TP53 target region was next monitored by
ChIP analysis. RPA32 and ATR were recruited to the TP53 target region at 30 min and 1 h after MMS treat-
ment, respectively (Figure S8B). TonEBP recruitment to this region peaked at 1 h after MMS treatment (Fig-
ures 3E and S8C). By contrast, the recruitment of SHPRH and USP1 to the region peaked at 2 and 4 h after
MMS treatment, respectively (Figure 3E and the top of Figure 3F). This sequential pattern of recruitment to
the DNA damage site was consistent with the pattern of interactions of SHPRH and USP1 with TonEBP (Fig-
ure 3E and the bottom of Figure 3F). SHPRH and USP1 recruitment decreased in response to small inter-
fering RNA (siRNA)-mediated silencing of TonEBP expression (Figures 3G and 3H), suggesting that
TonEBP recruited both SHPRH and USP1 to DNA damage sites.
TonEBP Protects the Replication Fork in Response to MMS Treatment
Because PCNA polyubiquitination promotes replication fork reversal in response to DNA damage (Vuja-
novic et al., 2017), we next hypothesized that TonEBP regulates replication fork reversal. A DNA combing
assay can detect fork reversal impairment by measuring unrestrained fork progression (Vujanovic et al.,
2017). The replication velocity depended on TonEBP without replication stress. Nonetheless, TonEBP
depletion caused a smaller reduction of replication velocity in response to MMS treatment (Figures
4A–4C). We additionally confirmed the specificity of an anti-ZRANB3 antibody bymeans of siRNA targeting
ZRANB3 (Figure S9A). Native 5-bromo-20-deoxyuridine (BrdU) detection (without DNA denaturation)
immediately after BrdU labeling for 5 min detects ssDNA upon DNA damage, including reversed forks
(Couch et al., 2013). The intensity of BrdU foci increased in response to MMS treatment, consistent with
another report (Nikolova et al., 2010) (Figures S9B and S9C). In agreement with the PCNA poly-
ubiquitination attenuation by the TonEBP knockdown, the intensity of native BrdU foci decreased.
Following DNA damage, a smaller reduction in fork velocity and slower single-stranded DNA accumulation
after the TonEBP knockdown suggested that TonEBP might promote the reversal of DNA replication forks.
The ZRANB3 DNA translocase is required for replication fork reversal upon DNA damage (Ciccia et al.,
2012). In line with the above data, the TonEBP knockdown decreased UV-induced ZRANB3 foci and
ZRANB3 recruitment to DNA damage sites (Figures 4D and 4E). In addition, we examined the importance
of the TonEBP RHD, which encircles DNA and is essential for the interaction with SHPRH or USP1 (Fig-
ure 1A). Full-length (FL) and Yc1 TonEBP restored UV-induced ZRANB3 focus formation and ZRANB3
recruitment to DNA damage sites upon UV irradiation. In contrast, expression of RHD-null (DRHD) TonEBP
or Yc1 DRHD did not restore UV-induced ZRANB3 focus formation and ZRANB3 recruitment to DNA dam-
age sites. Thus, TonEBP might be involved in template-switching DNA damage bypass pathway by pro-
moting PCNA polyubiquitination and subsequent fork reversal.
TonEBP Suppresses MMS-Induced Cell Death
The data presented above indicated that TonEBP participates in DNA damage tolerance by regulating
PCNA polyubiquitination. Defects in DNA damage tolerance lead to increased sister chromatid exchange
(SCEs), mutation frequency, and cell death in response to DNA damage. We therefore examined the effect
Figure 3. Continued
(E) Cells treated with 0.01% (v/v) MMSwere washed and incubated for up to 9 h as indicated. ChIP was performed using the anti-TonEBP, anti-SHPRH, or anti-
USP1 antibody as indicated. Region 13502–13724 (nucleotide positions) in intron 7 of TP53 from precipitated DNA was amplified by quantitative PCR. The
percentage of input in the precipitate is shown as the mean G SD, n = 3.
(F) Top: The results in (E) were fitted to curves. Bottom: Interactions of TonEBP with SHPRH and USP1 shown in (D) were formatted as a curve.
(G and H) HEK293 cells transfected with either scrambled (control) or TonEBP siRNA were treated with 0.01% (v/v) MMS. DNA precipitated by ChIP with the
anti-SHPRH (G) or anti-USP1 (H) antibody was amplified by quantitative PCR after 2 or 4 h, respectively, with the same primers as those used in Figure 3F.
Mean G SD, n = 4; **p < 0.01.
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of TonEBP deficiency on SCEs, mutagenesis, and cell survival in response to DNA damage. TonEBP knock-
down significantly increased SCEs and mutation frequency in response to MMS (Figures 5A–5D). Accord-
ingly, TonEBP knockdown had no effect on the survival of three cell lines (Figure 5E). Consistent with this
finding, TonEBP haploinsufficiency did not affect cellular survival in primary cultures of renal mesangial cells
(Figure 5F). TonEBP knockdown or TonEBP haploinsufficiency significantly decreased cell survival in
response to MMS, and this effect was mediated by the induction of apoptosis (Figures S10A and S10B).
MMS causes the formation of DNA adducts similar to those generated by UV irradiation (Marini and
Wood, 2002; Minca and Kowalski, 2011; Reynolds et al., 2004). TonEBP knockdown or TonEBP haploinsuf-
ficiency reduced cell survival in response to UV irradiation (Figures S10C and S10D). By contrast, cell survival
in response to HU or ionizing radiation (IR) was not affected by TonEBP knockdown (Figure S10E). Neither
HU nor IR produces bulky DNA adducts (Koc et al., 2004; Rothkamm et al., 2003), suggesting that TonEBP
mediates the tolerance to DNA damage associated with bulky DNA adduct formation. Collectively, these
Figure 4. TonEBP Promotes Replication Fork Reversal
(A) The TonEBP protein level was determined by western blot analysis. HEK293 cells transfected with scrambled siRNA (S)
or TonEBP-targeting siRNA (T). Whole-cell extracts were subjected to western blot analysis.
(B) Representative images of DNA fibers are shown.
(C) Analysis of the replication fork reversal in aDNAcombing assay. The iodo-deoxyuridine/chloro-deoxyuridine (IdU/CIdU) ratio
was measured in at least 200 well-isolated DNA fibers from three independent experiments; meanG SD, *p < 0.05, **p < 0.01.
(D and E) U2OS cells transfected with TonEBP-targeting siRNA (T) together with a plasmid expressing tagged Yc1, Yc1
DIPT, or Yc1 DRHD. U2OS cells irradiated with UV light (60 J/m2) (D) or microirradiated with 405-nm UV light (E) were
fixed and immunostained with the anti-ZRANB3 antibody. Right: The percentage of cells with ZRANB3 foci (D) and
intensity of UV light-induced ZRANB3 stripes (out of 50 nuclei) (E) expressed as the mean G SD, n = 3; *p < 0.05,
**p < 0.01. Scale bar, 2 mm.
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results meant that TonEBP prevents cell death, SCEs, and mutagenesis in response to DNA damage (in the
form of bulky DNA adduct formation), consistent with its role in DNA damage tolerance.
The RHD Is Essential for TonEBP Focus Formation and PCNA Polyubiquitination
Last, we examined the importance of TonEBP RHD.We used the mouse TonEBPD allele (DDBD), which rep-
resents the deletion of exons 6 and 7 of the TonEBP gene resulting in an in-frame deletion of the C-terminal
portion of the RHD (Figure 6A) (Go et al., 2004). In contrast to the formation of TonEBP foci in wild-type
mouse embryonic fibroblasts (MEFs) upon treatment with MMS, TonEBP foci were absent in DDBD
MEFs (Figure 6B), suggesting that the RHDwas required for TonEBP focus formation. RHD is also important
for the interaction with SHPRH associated with PCNA polyubiquitination (Figure 2C). Accordingly, PCNA
polyubiquitination after MMS treatment was significantly lower in DDBD MEFs (Figure 6C). DDBD MEFs
manifested higher sensitivity to MMS treatment (Figure 6D), whereas the knockdown of TonEBP in
DDBDMEFs (Figure 6E) did not further increase cell death after MMS treatment (Figure 6F). These findings
indicated that the RHD of TonEBP is important for DNA damage tolerance.
The role of RHD was confirmed by reconstitution experiments. PCNA polyubiquitination after MMS treat-
ment was restored via ectopic expression of FL or Yc1 TonEBP (Figures 7A and 7B). Similarly, after MMS
treatment, the recruitment of SHPRH to DNA damage sites in the TP53 gene (Figure 7C) as well as cell sur-
vival (Figure 7D), SCEs (Figure 7E), and mutation frequency (Figure 7F) were restored by FL and Yc1
TonEBP. In contrast, ectopic expression ofDRHD TonEBP orDRHD Yc1 TonEBP did not restore PCNA poly-
ubiquitination or affect SHPRH recruitment to DNA damage sites, cell survival, SCEs, and mutation fre-
quency after MMS treatment. Taken together, these results suggested that the RHD of TonEBP is necessary
for the formation of TonEBP foci and for the regulation of PCNApolyubiquitination, whereas the C-terminal
two-thirds of TonEBP are dispensable.
Figure 5. TonEBP Suppresses SCEs and Mutagenesis in Response to MMS Treatment
(A) The TonEBP protein level was determined by western blot analysis. HEK293 cells were transfected with scrambled
siRNA (S) or TonEBP-targeting siRNA (T). Whole-cell extracts were subjected for western blot analysis.
(B) Representative images of SCEs.
(C) For statistical analysis, SCEs after MMS treatment for 24 h were counted in 35 metaphase cells per group; meanG SD,
**p < 0.01.
(D) HEK293 cells transfected with the indicated siRNAs were treated with 0.01% (v/v) MMS for 1 h, followed by incubation
for 24 h. Mutation frequency was determined by the SupF plasmid mutagenesis assay; mean G SD, **p < 0.01.
(E) HEK293, HeLa, and U87-MG cell were transfected with the indicated siRNAs and treated with 0.01% (v/v) MMS. Live
cells were counted after 24 h (mean G SD, n = 4, *p < 0.05, **p < 0.01).
(F) Primary cultures of renal mesangial cells were prepared from TonEBP haploinsufficient mice (HET) and their wild-type
littermates (WT). Cells were treated with 0.01% (v/v) MMS, and live cells were counted (mean G SD, n = 4. **p < 0.01).
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DISCUSSION
The RHD of TonEBP is distinct from other the RHDs of Rel proteins, which bind asymmetric DNA sites.
TonEBP completely encircles its DNA target, and the DNA encirclement may increase the kinetic stability
of the TonEBP-DNA complex (Stroud et al., 2002). We hypothesized that just as other proteins that encircle
DNA (such as PCNA and minichromosomemaintenance; Costa et al., 2011; DeMarch and De Biasio, 2017),
TonEBP participates in DNA surveillance. We found that TonEBP formed foci in response to MMS treat-
ment and sequentially interacted with SHPRH and USP1, leading to PCNA polyubiquitination and subse-
quent deubiquitination. PCNA polyubiquitination triggers replication fork reversal in the DNA damage
bypass pathway. Consistent with these data, TonEBP was required for replication fork protection presum-
ably through fork reversal and DNA damage tolerance (Figure 8). The RHD of TonEBP was necessary for
focus formation, regulation of PCNA polyubiquitination, and DNA damage tolerance, suggesting that
DNA encirclement is essential for DNA damage surveillance by TonEBP.
PCNA polyubiquitination is necessary for DNA damage tolerance response because PCNA poly-
ubiquitination induces replication fork reversal. Nonetheless, the mechanism by which DNA damage is
detected leading to PCNA polyubiquitination by SHPRH and HLTF and deubiquitination by USP1 after
the bypass has remained unclear. The present data suggest that TonEBP senses DNA damage sites with
bulky adducts and sequentially recruits SHPRH to promote PCNA polyubiquitination and USP1 for
PCNA deubiquitination. Therefore, TonEBP provides a platform for the recruitment of SHPRH and USP1
in a temporal manner to regulate PCNA polyubiquitination in response to DNA damage. The sequential
recruitment of a ubiquitin ligase, SHPRH, and a deubiquitinating enzyme, USP1, to a DNA damage site
by TonEBP might mediate the formation of a platform to initiate and finish fork reversal. ZRANB3, a
polyubiquitin-recognizing protein, is recruited to the DNA damage sites for fork reversal (Ciccia et al.,
2012). PCNA polyubiquitinated by TonEBP and SHPRHmight allow ZRANB3 to move to DNA damage sites
to protect stalled replication forks and induce fork reversal for template switching in the DNA damage
bypass pathway (Vujanovic et al., 2017). After template switching for the DNA lesion bypass, the platform
Figure 6. The RHD of TonEBP Is Required for MMS-Induced TonEBP Focus Formation, PCNA Polyubiquitination,
and Cell Survival in Response to MMS Treatment
(A) The deleted portion of the TonEBP RHD in the TonEBPD allele is marked on the homodimer of TonEBP (PDB: 1IMH).
(B) MEFs from TonEBPD/D (DDBD) mice and their wild-type (WT) littermates were treated with 0.01% (v/v) MMS. TonEBP in
the nucleus was visualized by immunostaining. Representative images of the nucleus are shown in each condition. Scale
bar, 2 mm.
(C) MEFs were treated with 0.01% (v/v) MMS, and chromatin-bound PCNA was detected as described in Figure 3A.
(D) MEFs were treated with MMS at various doses as indicated, and live cells were counted; meanG SD, n = 5, *p < 0.05.
(E and F)DDBDMEFs were transfected with the indicated siRNAs. The cells were immunoblotted (E), and cell survival after
MMS treatment was analyzed (F); mean G SD, n = 3.
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of polyubiquitinated PCNA is inactivated by TonEBP and USP1, displacing several proteins such as
ZRANB3 from the DNA damage sites.
Defects in TonEBP caused sensitivity to MMS and UV irradiation, but not to HU or IR. UV irradiation and
MMS produce bulky DNA adducts, which cause DNA replication stalling (Minca and Kowalski, 2011). Unlike
the stimulatory effect of MMS on the levels of PCNA polyubiquitination, HU or IR treatment causes little or
no PCNA polyubiquitination (Motegi et al., 2006, 2008). Therefore, TonEBP might be a key sensor to pro-
mote PCNA ubiquitination (mono- to poly-) at bulky DNA adduct-related damage sites.
Proteins regulating gene transcription also function in other DNA processes such as DNA replication and
repair. A recent study showed that RNA m6A (methylation of an A base), which is important for many RNA
metabolic processes, is highly enriched at UV irradiation-induced DNA damage sites for Polk recruitment
(Xiang et al., 2017). SHPRH induces rRNA synthesis by recruiting RNA polymerase I to the rDNA promoter
via the recognition of different histone methylation codes (Lee et al., 2017). In addition, DNA replication
Figure 7. The RHD of TonEBP Is required for MMS-Induced PCNA Polyubiquitination, Cell Survival, and Genomic
Stability in Response to MMS Treatment
(A–F) HEK293 cells were transfected with TonEBP siRNA and a plasmid expressing full-length TonEBP (FL), TonEBP DRHD
(DRHD), Yc1, or Yc1 DRHD. (A) Immunoblots of TonEBP. (B) PCNA polyubiquitination was analyzed in chromatin-bound
fractions after MMS treatment. (C) SHPRH ChIP was performed as described in Figure 3D, meanG SD, n = 3, *p < 0.05,
**p < 0.01. (D) Cell survival after MMS treatment was measured; meanG SD, n = 3. (E) SCEs were analyzed as described in
Figure 5C; mean G SD, **p < 0.01. (F) The SupF plasmid mutagenesis assay was performed as described in Figure 5D;
mean G SD, n = 3, **p < 0.01.
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fork reversal can occur in response to high levels of transcription caused by a potential replication-tran-
scription head-on collision (De Septenville et al., 2012; Trautinger et al., 2005). Therefore, proteins involved
in transcription or replication repair may play a role in replication repair or transcription, respectively.
Consistent with this idea, transcription factor TonEBPmight take part in DNA damage bypass by regulating
PCNA polyubiquitination to promote replication fork reversal.
There are a number of E3 ligases in the TonEBP interactome. In this study, we found that TonEBP selectively
induces PCNA polyubiquitination through SHPRH after MMS-induced damage. We believe that UV light
sensitivity caused by the TonEBP knockdown could be due to other E3 ligases interacting with TonEBP
and presumably through PCNA polyubiquitination.
In summary, TonEBP regulates DNA damage tolerance through sequential interactions with SHPRH and
USP1. The initial sensing of bulky DNA adducts by TonEBP and the provision of a platform for PCNA poly-
ubiquitination upon MMS treatment potentially for fork reversal as well as the platform disassembly to end
fork reversal constitute the initial and final molecular mechanisms of template switching. Because template
switching mediated by fork reversal induced by PCNA polyubiquitination is an error-free model of DNA
damage bypass, it could be a biomarker predicting the aggressiveness of tumors with different degrees
of mutagenesis. This notion suggests that it is possible to select chemotherapeutic agents based on the
expression level of TonEBP according to the mutagenesis burden of tumors.
Limitations of the Study
In our study, only MMS was selected as a DNA-damaging agent inducing PCNA polyubiquitination.
Although DNA-damaging agents other than MMS, e.g., UV light, HU, and IR, could induce DNA damage,
our study revealed that TonEBP specifically performs its function in response to UV irradiation or MMS.
Thus, further studies on UV light-induced PCNA polyubiquitination are needed. Nevertheless, because
our study shows that UV-induced PCNA polyubiquitination rarely occurs in mammalian cells, we believe
that TonEBP-dependent UV light-induced DNA damage response is minimal or has an alternative mecha-
nism. Therefore, we are currently investigating a pathway independent of PCNA polyubiquitination in
response to UV irradiation.
Figure 8. A Model of TonEBP Function in MMS-Induced PCNA Polyubiquitination
Recruitment of TonEBP to DNA damage sites activates SHPRH to promote PCNA polyubiquitination through protein
interactions. PCNA deubiquitination is necessary for the completion of fork reversal, and template switching is mediated
by TonEBP-driven recruitment of USP1-UAF1 to DNA damage sites.
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We proposed that TonEBP stabilizes a DNA replication fork in response to DNA damage. We suggested
that this phenomenon may be mediated by fork reversal according to previous observations that PCNA
polyubiquitination promotes fork reversal and some of our results. Nonetheless, we could not obtain direct
evidence of fork reversal by electron microscopy owing to a technical issue. This topic should be investi-
gated later.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.07.021.
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Transparent Methods 
Cells and reagents 
HEK293 and HeLa cells and MEFs were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% of fetal bovine serum (FBS; Thermo Fisher Scientific 
Inc., Waltham, MA, USA), penicillin, and streptomycin (100 U/ml and 100 μg/ml, 
respectively; GE Healthcare Life Sciences, Logan, UT, USA). Cells were maintained at 
37°C in an incubator with 5% of CO2. Cells were pretreated with MMS (Sigma-Aldrich, St. 
Louis, MO, USA) for various periods. Antibodies used for immunoblotting or IP were 
obtained from various companies (see Table S2). Cells were transfected with 
Lipofectamine 2000 or Lipofectamine RNAimax (Invitrogen, Carlsbad, CA, USA). siRNA 
duplexes were purchased from Integrated DNA Technologies (Coralville, IA, USA). 
Sources of all cells, reagents, and DNA constructs are listed in Table S2.  
Immunofluorescence, microscopy, and image analysis 
Cells were plated on LabTek chamber slides (Thermo Fisher Scientific) and incubated for 
1 day before fixation with 100% methanol at 20°C for 30 minutes. For chromatin-bound 
proteins, cells were pretreated with 0.5% Triton X-100 for two minutes before fixation. For 
BrdU (Thermo Fisher Scientific) labeling, 20 µM BrdU was added for incubation for the 
variousperiods before fixation. For UV microirradiation, UVA laser (55 mW) irradiation was 
performed by means of a Palm MicroBeam laser microdissection workstation. The fixed 
cells were stained with the appropriate primary antibodies overnight at 4°C. After washes 
with 0.05% Triton X-100, Alexa Fluor–conjugated secondary antibodies were added and 
incubated for one hour. For BrdU detection, BrdU-labeled cells were fixed with 4% 
paraformaldehyde for five minutes after immunostaining. The cells were then treated with 
 3 
4 N HCl for 10 minutes at room temperature (25℃). Next, the cells were washed with 
phosphate-buffered saline (PBS) and stained with a rat anti-BrdU antibody followed by 
Alexa Fluor–conjugated secondary antibody. The stained cells were mounted. Alexa Fluor 
488–, 568–, and 633–conjugated secondary antibodies were purchased from Invitrogen. 
TonEBP interactome analysis  
To isolate TonEBP-interacting proteins, HEK293 cells were transfected with the 
pcDNA5/FRT empty vector or pcDNA5/FRT-TonEBP-Flag plasmid. The cells were lysed 
in 1 ml of RIPA buffer supplemented with a protease inhibitor cocktail and 0.5 mM 
phenylmethylsulfonyl ﬂuoride at 24 hours post-transfection. Cell extracts were recovered 
by centrifugation at 12,000 rpm (Eppendorf, 5424R) for 15 minutes at 4°C. The cleared 
supernatants were collected, and the cell lysates were mixed with 50 ml (50% slurry) of 
anti-Flag M2 resin (Sigma-Aldrich) and incubated at 4°C for four hours. After centrifugation 
at 2500 rpm (Eppendorf, 5424R) for five minutes, the supernatants were discarded, and 
the collected resin samples were washed in 1 ml of RIPA lysis buffer five times. Flag-
tagged TonEBP and bound proteins were eluted with excessive amounts of the 3× Flag 
peptide (Sigma-Aldrich). Eluted proteins were subjected to immunoblotting. The molecular 
identities of the eluted proteins were determined by mass spectrometry. 
IP 
For preparation of lysates for IP, cells were washed three times with ice-cold PBS and 
lysed in RIPA buffer as described previously (Lee et al., 2016). An appropriate antibody 
was added to lysates and incubated overnight at 4°C, followed by incubation with Protein 
A/G Sepharose beads (GE Healthcare Sciences). After extensive washing with RIPA lysis 
buffer, complexes were eluted and analyzed by immunoblotting. 
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Immunoblotting 
Cell lysis for protein extraction was performed as described elsewhere (Lee et al., 2015). 
Protein concentration was measured with the BCA Protein Assay System (Pierce, 
Rockford, IL, USA). Equal amounts of protein from each sample were separated by SDS-
PAGE and immunoblotted using specific primary antibodies. Horseradish peroxidase 
(HRP)-conjugated mouse, rabbit, and goat secondary antibodies were used for detection. 
The antigen–antibody binding was detected by means of enhanced chemiluminescence 
western blotting detection reagents (GE Healthcare Life Sciences). 
Quantitative PCR 
Quantitative PCR was performed using SYBR Green I Master and LightCycler 480 II 
(Roche, Rotkreuz, Switzerland). Measured threshold cycle (Ct) values were normalized to 
those of cyclophilin A. 
ChIP 
ChIP was performed as previously described (Lee et al., 2016). Briefly, HEK293 cells were 
treated with MMS for the various periods (Sigma-Aldrich), and chromatin was crosslinked 
with 1% formaldehyde before neutralization with 0.125 M glycine. After lysis and sonication 
(12 sonication cycles with Bioruptor NGS) to obtain DNA fragments between 250 and 500 
bp), crosslinked chromatin was precleared with normal rabbit IgG or mouse IgG and 
Protein A Sepharose beads before IP with an anti-TonEBP, anti-SHPRH, or anti-USP1 
antibody. Eluted protein–DNA complexes were washed extensively, and crosslinks in 
complexes were reversed by heating and proteinase K (Roche) treatment. Quantification 
of associated DNA was performed by quantitative PCR analysis with primers for TP53 
intron 7 (positions 13502–13724), forward primer: 5-CCTCTTACCGATTTCTTCCA-3 
and reverse primer: 5-AGGTCCTACCTGTCCCATTTA-3, as described previously (Jiang 
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and Sancar, 2006).  
Cell survival and apoptosis analysis 
Cells grown in the presence or absence of MMS were trypsinized and counted at the 
various time points. For a terminal deoxynucleotidyl transferase dUTP nick-end labeling 
(TUNEL) assay, cells grown on coverslips were fixed in 4% formaldehyde and processed 
via the Apoptosis Detection System (Promega, Madison, WI, USA). Coverslips were 
analyzed under a LSM780NLO confocal microscope. 
A SupF Plasmid Mutagenesis Assay 
Control or TonEBP siRNA was introduced into HEK293T cells with RNAiMAX (Invitrogen). 
After 24 hours, shuttle plasmid pSP189 was cotransfected with control or TonEBP siRNA 
into HEK293T cells. After incubation at 37C and 5% CO2 for 24 hours, the cells were 
treated with 0.01% (v/v) MMS and allowed to recover in a fresh medium for another 24 
hours. Plasmid DNA was isolated by means of the Spin Miniprep Kit (QIAGEN, 
Germantown, MD, USA). Recovered plasmid DNA was digested with Dpn I (Stratagene, 
La Jolla, CA, USA) and RNase I (Thermo Fisher Scientific), and introduced by heat shock 
into Escherichia coli MBM7070 carrying an amber mutation in the lacZ gene. After heat 
shock, the MBM7070 cell suspension was spread on Luria–Bertani (LB) agar plates with 
ampicillin, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal), and isopropyl-β-D-
thiogalactoside. Mutation frequencies were measured by dividing the number of white 
colonies by the total number of colonies. 
An SCE assay 
HEK293T cells were cultured in the presence of 25 μg/ml BrdU for fourty eight hours. 
The cells were incubated for four hours with 0.2 μg/ml colcemid and then harvested by 
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trypsinization. The cells were then swollen in 75 mM KCl for 15 minutes at 37°C and fixed 
with methanol:acetic acid (3:1) twice. A drop of the cell suspension was placed onto glass 
microscope slides. The slides were treated with 1 μg/ml Hoechst 33258 (Invitrogen) for 30 
minutes and then exposed to 265 nm UV light for 30 minutes. After that, the slides were 
incubated for 15 minutes in 2 SSC (Saline-sodium citrate buffer) at 65°C and then stained 
with a 5% Giemsa solution. Images were acquired using a fluorescence microscope (BX53; 
Olympus). At least 35 metaphase cells were chosen randomly from each group. 
 
The molecular DNA combing assay 
HEK293T cell were labeled for 30 minutes with 50 μM CldU (Sigma-Aldrich 
C6891) followed by 30 minutes of labeling with 250 μM IdU (Sigma-Aldrich I7125). To 
measure DNA replication rates, the cells were treated with 0.01% MMS and harvested. 
The cells were embedded in low-melting agarose (Bio-Rad, 161-3112) followed by DNA 
extraction. To stretch the DNA fibers, 22  22 mm silanized coverslips (Genomic Vision) 
were dipped into the DNA solution for 13 minutes and pulled out at a constant speed (300 
μm/s) using Molecular Combing System (Genomic Vision MCS-001). The coverslips were 
baked for four hours at 60C and incubated with 4N HCl for denaturation. CldU- and IdU-
labeled tracts were detected by two hours incubation at room temperature (25℃) with a 
rat anti-BrdU antibody (dilution 1:100 detects BrdU and CldU; Abcam 6326) and a mouse 
anti-BrdU antibody (1:10, detects BrdU and IdU; Becton Dickinson 347580). The slides 
were fixed in 4% paraformaldehyde in PBS and incubated for one hour at room 
temperature (25℃) with an Alexa Fluor 488–conjugated goat anti-rat IgG antibody (dilution 
1:100, A21208; Molecular Probes/Thermo Fisher) or an Alexa Fluor 568–conjugated goat 
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anti-mouse IgG antibody (dilution 1:100, A21124; Molecular Probes/Thermo Fisher). 
Finally, the coverslips were mounted with the ProLong Gold Antifade Reagent (Molecular 
Probes) and stored at −20C. DNA fibers were examined under a Carl Zeiss microscope 
with Axio Observer 7 & ApoTome 2 (Motorized Fluorescence Microscope with Grid 
Projection) 63 objective. For each experiment, a total of 200 DNA fibers were analyzed, 
and the length of DNA fibers was measured in Adobe Photoshop. 
Separation of nuclear and chromatin-bound fractions 
The nuclear fraction was extracted using the Nuclear Extraction Kit (Pierce). The 
chromatin-bound fraction was extracted as described previously (Motegi et al., 2006). 
Quantification and statistical analysis 
All statistical analyses were performed by Student’s t test. In figures, n means the number 
of biological replicates. 
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Supplementary figure legends 
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Figure S1. TonEBP interacts with SHPRH, USP1, HLTF, and UAF1, related to Figure 1 
(A) HeLa cells treated with 60 J/m2 ultraviolet irradiation (UV), 2.5 mM hydroxyurea (HU), 
or 60 ng/ml mitomycin C (MMC) for 30 minutes were fixed and immunostained with the 
anti-TonEBP antibody. Representative images of the nucleus are shown for each group. 
Scale bar, 2 μm. (B) HEK293 cells were transfected with plasmids expressing proteins 
Flag-HA-TonEBP and Myc-SHPRH. Cell lysates were subjected to IP with the anti-HA 
antibody. Precipitated proteins were detected with the various antibodies. (C) HEK293 
cells were transfected with plasmids expressing Flag-HA-TonEBP and Myc-USP1. Cell 
lysates were subjected to IP with the anti-HA antibody. Precipitated proteins were detected 
with the various antibodies. (D) HEK293 cells were transfected with plasmids expressing 
Myc-SHPRH and Flag-USP1. Cell lysates were subjected to IP with the anti-Flag antibody. 
Precipitated proteins were detected with the various antibodies. (E) HEK293 cells were 
transfected with plasmids expressing Flag-HA-TonEBP and Myc-UAF1. Cell lysates were 
subjected to IP with the anti-HA antibody. Precipitated proteins were detected with the 
various antibodies. (F) HEK293 cells were transfected with plasmids expressing proteins 
Flag-TonEBP, Myc-SHPRH, and HA-USP1. Cell lysates were subjected to IP with the anti-
Flag antibody. Precipitated proteins were analyzed with the various antibodies. Benzonase 
(2500 U) was added during the IP reaction to eliminate indirect interactions through DNA. 
Figure S2. Heterodimerization of Yc1 with endogenous FL TonEBP does not affect 
the interaction with SHPRH and USP1, related to Figure 2 
(A) HEK293 cells were transfected with TonEBP-targeting siRNA (T) followed by plasmids 
expressing Myc-tagged SHPRH together with Flag-tagged Yc1, Yc1 ΔIPT, or Yc1 ΔRHD. 
The proteins immunoprecipitated with the anti-Myc antibody were detected with the anti-
Flag antibody. (B) HEK293 cells were transfected with TonEBP-targeting siRNA (T) 
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followed by a plasmid expressing HA-USP1 together with a plasmid expressing Flag-
tagged Yc1, Yc1 ΔIPT, or Yc1 ΔRHD. The proteins immunoprecipitated with the anti-HA 
antibody were detected with the anti-Flag antibody. 
Figure S3. Effects of SHPRH or USP1 on PCNA polyubiquitination, related to Figure 
3  
(A) HEK293 cells transfected with scrambled (control) siRNA or SHPRH-targeting siRNA 
were treated with 0.01% (v/v) MMS for one hour as indicated. PCNA bound to chromatin 
was immunoprecipitated and detected with the anti-PCNA antibody after four hours. (B) 
HEK293 cells transfected with scrambled siRNA or USP1-targeting siRNA were treated 
with 0.01% (v/v) MMS for one hour as indicated. PCNA bound to chromatin was 
immunoprecipitated and detected with the anti-PCNA antibody after four hours. 
Figure S4. Effects of SHPRH or USP1 effects on TonEBP amount–dependent PCNA 
polyubiquitination, related to Figure 3 
(A) HEK293 cells transfected with TonEBP-targeting siRNA (T) and SHPRH-targeting 
siRNA (S) followed by TonEBP-expressing plasmids at various doses as indicated were 
treated with 0.01% (v/v) MMS for one hour. PCNA bound to chromatin was 
immunoprecipitated and detected with the anti-PCNA antibody. (B) HEK293 cells 
transfected with TonEBP-targeting siRNA (T) and USP1-targeting siRNA (U) followed by 
TonEBP-expressing plasmids at various doses as indicated were treated with 0.01% (v/v) 
MMS for one hour. PCNA bound to chromatin was immunoprecipitated and detected with 
the anti-PCNA antibody. 
Figure S5. mRNA expression levels of SHPRH and USP1 are not affected by TonEBP, 
related to Figure 3 
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(A) HEK293 cells were transfected with the indicated siRNAs, and proteins were detected 
with the indicated antibodies. (B) HEK293 cells were transfected with the indicated siRNAs 
and treated with 0.005% (v/v) MMS for one hour, followed by incubation for 24 hours. 
Proteins were detected with the indicated antibodies. S and T indicate scrambled siRNA 
and TonEBP siRNA. 
Figure S6. Effects of TonEBP on UV light–induced PCNA polyubiquitination, related 
to Figure 3 
(A) HEK293 cells transfected with scrambled siRNA (S) or TonEBP-targeting siRNA (T) 
were irradiated with 60 J/m2 UV light. PCNA bound to chromatin was immunoprecipitated 
and detected with the anti-PCNA antibody after four hours. (B) HEK293 cell lysates were 
subjected to IP with the indicated antibodies. Cells treated with normal serum (Serum) 
served as a negative control. The anti-TonEBP antibody was employed for IP. Precipitated 
proteins were detected with the indicated antibodies. (C) HEK293 cells were transfected 
with scrambled siRNA or SHPRH-targeting siRNA. Cell lysates were subjected to IP with 
the indicated antibodies. Cells treated with normal serum (Serum) served as a negative 
control. The anti-TonEBP antibody was used for IP. Precipitated proteins were detected 
with the indicated antibodies. 
Figure S7. The TonEBP–SHPRH–USP1 complex, related to Figure 3 
HEK293 cells were transfected with the plasmids expressing proteins HA-TonEBP, Myc-
SHPRH, and Flag-USP1. Cell lysates were subjected to IP with the anti-Flag or anti-Myc 
antibody. Precipitated proteins were detected with the indicated antibodies. 
Figure S8. TonEBP, SHPRH, and USP1 form a complex, and TonEBP is recruited to 
DNA damage sites, related to Figure 3  
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(A) Location of DNA damage sites in intron 7 of the TP53 gene. The region from nucleotide 
position 13502 to 13724 was amplified by quantitative PCR for ChIP. (B, C) HEK293 cells 
were incubated without MMS (-), or with 0.01% (v/v) MMS for one hour, followed by 
incubation for a half or one hour as indicated. ChIP was performed using anti-ATR and 
anti-RPA32 antibodies (B) and the anti-TonEBP antibody as indicated (C). The percentage 
of input in the precipitates is shown. Mean ± SD, n=3  
 
Figure S9. Specificity of the anti-ZRANB3 antibody and the necessity of TonEBP for 
MMS-induced replication fork protection, related to Figure 4 
(A) U2OS cells were transfected with scrambled siRNA or ZRANB3-targeting siRNA. After 
that, proteins were detected with the indicated antibodies. (B) HeLa cells were transfected 
with scrambled siRNA or TonEBP-targeting siRNA. The cells were then pulse-labeled with 
20 µM BrdU for 10 minutes and treated with 0.01% (v/v) MMS for one hour before fixation 
and immunostaining for BrdU. Representative images of the nucleus inside white lines are 
presented for each group. Scale bar, 2 μm. (C) BrdU signal intensity in each nucleus was 
measured in 200 cells from each group. Mean + SD, *p < 0.05, **p < 0.01. 
Figure S10. TonEBP promotes cell survival after treatment with UV light but not HU 
or IR, related to Figure 5 
(A) HeLa cells were transfected with the indicated siRNAs and treated with 0.01% (v/v) 
MMS. The TUNEL assay was performed, and cells were stained with propidium iodide 
(PI). Arrowheads indicate cells positive for PI and TUNEL signals. Representative images 
of the nucleus inside white lines are shown for each group. Scale bar, 20 μm. (B) 
Percentages of double-positive cells were measured among 300 cells from each group. 
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Mean ± SD, *p < 0.05. (C) HeLa cells were transfected with the indicated siRNAs and 
treated with 60 J/m2 UV irradiation. Live cells were counted after 24 hours. Mean ± SD, n 
= 5, *p < 0.05. (D) Primary cultures of renal mesangial cells were derived from TonEBP 
haploinsufficient mice (HET) and their wild-type littermates (WT). Mean ± SD, n = 5, *p < 
0.05, **p < 0.01. Cells were treated with 60 J/m2 UV irradiation, and live cells were counted 
after 24 hours. (E) HeLa cells were transfected with the indicated siRNAs and treated for 
24 hours with 2.5 mM HU or 10 Gy IR. Live cells were counted. Mean ± SD, n = 5 
 
 
 
 
 
 
 
 
 
 
 
